DNA flow cytometry in surgically treated lung cancer--prognostic significance.
Although DNA aneuploidy and high proliferative activity (S-phase fraction, SPF) of tumour cells, measured by flow cytometry, have proved to be indicators of poor prognosis in most solid tumours, there have been conflicting results in lung cancer studies. During a four-year period we studied the prognostic significance of DNA ploidy and SPF in 99 surgically treated lung cancer patients. Flow cytometric analysis was done from archival, formalin-fixed, paraffin-embedded tumour specimens. DNA index and SPF were determined, using MultiCycle software with sliced nuclear correction to compensate for debris. There were 61 DNA diploid and 38 DNA aneuploid tumours. The median SPF was 10.2%. Neither ploidy nor SPF was associated with previously known prognostic factors. Survival was poorer in patients with aneuploid tumours than in the other patients, but the difference was not statistically significant. DNA ploidy and SPF thus do not seem to be useful prognostic indicators in surgically treated lung cancer.
Ikonen
J T
JT
Department of Surgery, Tampere University Hospital, Finland. jari.ikonen@sijoitusmiehet.fi
Ojala
A
A
Salenius
J P
JP
Mattila
J
J
Riekkinen
H
H
Wigren
T
T
D000368:Aged; D000782:Aneuploidy; D002453:Cell Cycle; D004273:DNA, Neoplasm / Q000235:genetics*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D008297:Male; D011003:Ploidies; D011379:Prognosis; D016196:S Phase; D015996:Survival Rate
D004273:DNA, Neoplasm